Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Mon, 09/27/10 - 05:40 pm
Tags:
Ariad Pharmaceuticals, Corcept Therapeutics, ridaforolimus, Merck, Cushing's disease, Corlux, Novartis
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Tags:
Novartis, MS, multiple sclerosis, Gilenya
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sun, 09/26/10 - 12:24 pm
Tags:
Novartis, Merck KGaA, Gilenya, multiple sclerosis, cladribine, Biogen Idec, Bayer, Teva Pharmaceuticals
Novartis International AG: Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients
Reuters
Fri, 09/24/10 - 12:19 pm
Tags:
Novartis, TOBI Podhaler, cystic fibrosis
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Bloomberg
Fri, 09/24/10 - 11:44 am
Tags:
Novartis, Zometa, Aredia
Novartis deal over, Alnylam cuts staff
Bizjournals.com
Fri, 09/24/10 - 11:16 am
Tags:
Novartis, Alnylam, layoffs, RNAi
Novartis to Sell U.S. Rights to Enablex
TheStreet.com
Fri, 09/24/10 - 09:58 am
Tags:
Novartis, Enablex, Warner Chilcott, overactive bladder
Gilenya: A Blockbuster in Due Time
Motley Fool
Fri, 09/24/10 - 09:55 am
Tags:
Gilenya, MS, multiple sclerosis, Novartis
Novartis Cushing's Drug Passes Late-Stage Test
TheStreet.com
Wed, 09/22/10 - 09:58 am
Tags:
Novartis, Cushing's disease
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wed, 09/22/10 - 09:53 am
Tags:
FDA, Gilenia, Novartis, Gilenya, MS, multiple sclerosis
Novartis Aims for China Trial of Novel Cancer Drug in 2013
Seeking Alpha
Tue, 09/21/10 - 11:14 am
Tags:
Novartis, China, cancer
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Minyanville
Tue, 09/21/10 - 09:19 am
Tags:
Novartis, Gilenia, FDA, MS, multiple sclerosis
The Next Big Rare Disease Drug?
Forbes
Wed, 09/15/10 - 09:46 pm
Tags:
Incyte, Novartis, Janus kinase, AstraZeneca, Eli Lilly, Sanofi
Savient Investors Expect a Sale
TheStreet.com
Wed, 09/15/10 - 08:06 am
Tags:
Savient, M&A, gout, FDA, Krystexxa, JNJ, Pfizer, Amgen, Novartis, Bristol-Myers Squibb
Did Dendreon Open Doors For Opexa Partnerships?
Yahoo/IndieResearch
Mon, 09/13/10 - 04:02 pm
Tags:
Opexa, Dendreon, stem cells, Novartis
Novartis's Experimental Meningitis Vaccine Meets Goals in Late-Stage Study
Bloomberg
Mon, 09/13/10 - 12:54 pm
Tags:
meningitis, vaccines, Novartis
Alnylam Evenly Poised
Yahoo/Zacks.com
Fri, 09/10/10 - 08:15 am
Tags:
Alnylam, Novartis, Biogen Idec, Roche, Isis Pharmaceuticals, Cubist Pharmaceuticals, Takeda, earnings
Migraine Medication Developers Feeling No Pain
Minyanville
Thu, 09/9/10 - 05:50 pm
Tags:
migraines, MAP Pharmaceuticals, Novartis, Valeant Pharmaceuticals, Biovail, Allergan, Botox, Migranal, Levadex, Zogenix
Biggest Battles in Biopharma
Fierce Pharma
Wed, 09/8/10 - 11:33 am
Tags:
Sun Pharma, Taro, Pfizer, Warner-Lambert, Aventis, Sanofi-Synthelabo, Astellas, OSI Pharmaceuticals, King, Alpharma, Novartis, Carl Icahn, Bristol-Myers Squibb, Alcon, Genzyme
Teva Wins Copaxone Protection
Forbes
Tue, 09/7/10 - 05:03 pm
Tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis, patents, Novartis, Momenta

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.